These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 37236245)
1. Correlation between kisspeptin and biochemical markers in obese and non-obese women with polycystic ovary syndrome. Gao M; Tao X; Zhang Q; He W; Zhao T; Yuan T Gynecol Endocrinol; 2023 Dec; 39(1):2215869. PubMed ID: 37236245 [No Abstract] [Full Text] [Related]
2. Adverse Effects of Selected Markers on the Metabolic and Endocrine Profiles of Obese Women With and Without PCOS. Daghestani MH; Daghestani MH; Warsy A; El-Ansary A; Omair MA; Omair MA; Hassen LM; Alhumaidhi EM; Al Qahtani B; Harrath AH Front Endocrinol (Lausanne); 2021; 12():665446. PubMed ID: 34122339 [TBL] [Abstract][Full Text] [Related]
3. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276 [TBL] [Abstract][Full Text] [Related]
4. [Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome]. Hu WH; Qiao J; Zhao SY; Zhang XW; Li MZ Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):487-91. PubMed ID: 17068620 [TBL] [Abstract][Full Text] [Related]
5. A comparative study of serum Kisspeptin levels among women with Polycystic Ovary Syndrome and normal fertile women. Hassan Ali MA; Mohamad SR J Pak Med Assoc; 2021 Dec; 71(Suppl 8)(12):S97-S100. PubMed ID: 35130228 [TBL] [Abstract][Full Text] [Related]
6. Serum kisspeptin levels correlated with anti-mullerian hormone levels in women with and without polycystic ovarian syndrome. Mut A; Erel CT; İnan D; Öner YÖ Gynecol Endocrinol; 2021 May; 37(5):462-466. PubMed ID: 32964765 [TBL] [Abstract][Full Text] [Related]
7. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Piouka A; Farmakiotis D; Katsikis I; Macut D; Gerou S; Panidis D Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E238-43. PubMed ID: 18957615 [TBL] [Abstract][Full Text] [Related]
8. Is there a role for kisspeptin in pathogenesis of polycystic ovary syndrome? Gorkem U; Togrul C; Arslan E; Sargin Oruc A; Buyukkayaci Duman N Gynecol Endocrinol; 2018 Feb; 34(2):157-160. PubMed ID: 28933574 [TBL] [Abstract][Full Text] [Related]
9. Effects of kisspeptin on pathogenesis and energy metabolism in polycystic ovarian syndrome (PCOS). Wang T; Han S; Tian W; Zhao M; Zhang H Gynecol Endocrinol; 2019 Sep; 35(9):807-810. PubMed ID: 30957568 [TBL] [Abstract][Full Text] [Related]
10. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome]. Li Y; Wei LN; Xiong YL; Liang XY Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609 [TBL] [Abstract][Full Text] [Related]
11. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome]. Li X; Lin JF Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817 [TBL] [Abstract][Full Text] [Related]
12. Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women. El-Eshmawy MM; Ibrahim A; Bahriz R; Shams-Eldin N; Mahsoub N BMC Endocr Disord; 2022 Dec; 22(1):315. PubMed ID: 36514085 [TBL] [Abstract][Full Text] [Related]
13. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age]. Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740 [TBL] [Abstract][Full Text] [Related]
14. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome. Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233 [TBL] [Abstract][Full Text] [Related]
15. rs4889 polymorphism in KISS1 gene, its effect on polycystic ovary syndrome development and anthropometric and hormonal parameters in Saudi women. Albalawi FS; Daghestani MH; Daghestani MH; Eldali A; Warsy AS J Biomed Sci; 2018 May; 25(1):50. PubMed ID: 29848339 [TBL] [Abstract][Full Text] [Related]
16. Role of kisspeptin in polycystic ovary syndrome (PCOS). Emekci Ozay O; Ozay AC; Acar B; Cagliyan E; Seçil M; Küme T Gynecol Endocrinol; 2016 Sep; 32(9):718-722. PubMed ID: 27003383 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of biochemical, endocrine, and metabolic biomarkers for the early diagnosis of polycystic ovary syndrome among non-obese Saudi women. Daghestani MH Int J Gynaecol Obstet; 2018 Aug; 142(2):162-169. PubMed ID: 29745981 [TBL] [Abstract][Full Text] [Related]
18. Kisspeptin Variations in Patients with Polycystic Ovary Syndrome-A Prospective Case Control Study. Akad M; Socolov R; Furnică C; Covali R; Stan CD; Crauciuc E; Pavaleanu I Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744039 [No Abstract] [Full Text] [Related]
19. Circulating kisspeptin and anti-müllerian hormone levels, and insulin resistance in women with polycystic ovary syndrome: A systematic review, meta-analysis, and meta-regression. Pérez-López FR; Ornat L; López-Baena MT; Santabárbara J; Savirón-Cornudella R; Pérez-Roncero GR Eur J Obstet Gynecol Reprod Biol; 2021 May; 260():85-98. PubMed ID: 33744505 [TBL] [Abstract][Full Text] [Related]
20. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women? Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]